Matrix metalloproteinases and tissue inhibitor of metalloproteinase-1 in sarcoidosis and IPF

European Respiratory Journal

Volumn 20, Issue 5, 2002, Pages 1220-1227

  Henry, M T ^a   McMahon, K ^a   Mackarel, A J ^a   Prikk, K ^a   Sorsa, T ^a   Maisi, P ^a   Sepper, R ^a   FitzGerald, M X ^a   O'Connor, C M ^a  

^a LEEDS GENERAL INFIRMARY   (United Kingdom)

Author keywords

Collagenases; Idiopathic pulmonary fibrosis; Matrix metalloproteinases; Sarcoidosis; Tissue inhibitor of metalloproteinase 1

Indexed keywords

COLLAGENASE 3; GELATINASE B; INTERSTITIAL COLLAGENASE; ISOENZYME; MATRIX METALLOPROTEINASE; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COLLAGEN DEGRADATION; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME STRUCTURE; FEMALE; FIBROBLAST; FIBROSING ALVEOLITIS; HUMAN; HUMAN TISSUE; LUNG LAVAGE; LUNG PARENCHYMA; LUNG SARCOIDOSIS; MALE; NEUTROPHIL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN FAMILY; PROTEIN FUNCTION; WESTERN BLOTTING;

AGED; BLOTTING, WESTERN; BRONCHOALVEOLAR LAVAGE FLUID; COLLAGENASES; FEMALE; HUMANS; MALE; MATRIX METALLOPROTEINASE 8; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; PULMONARY FIBROSIS; SARCOIDOSIS, PULMONARY; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 0036848469     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.02.00022302     Document Type: Article

References (32)

1. Crystal RG, Bitterman PB, Rennard SI, Hance K. Interstitial lung disease of unknown cause: disorders characterized by chronic inflammation of the lower respiratory tract. N Engl J Med 1984; 310: 154-166.
2. Peters CA, Freeman MR, Fernandez CH, Stephan J, Wiederschain DG, Moses MH. Dysregulated proteolytic balance as the basis of excess extracellular matrix in fibrotic disease. Am J Physiol 1997; 272: 1960-1965.
3. Woessner JF. The family of matrix metalloproteinases. Ann NY Acad Sci 1994; 732: 11-21.
4. O'Connor CM, FitzGerald MX Matrix metalloproteases and lung disease. Thorax 1994; 49: 602-609.
5. Parks WC. Matrix metalloproteinases in repair. Wound Repair Regen 1999; 7: 423-432.
6. Dunsmore SE, Rannels DE. Extracellular matrix biology in the lung. Am J Physiol 1996; 270: L3-L27.
7. Cole AA, Chubinskaya S, Schumacher B, et al. Chondrocyte matrix metalloproteinase-8. Human articular chondrocytes express neutrophil collagenase. J Biol Chem 1996; 271: 11023-11026.
8. Hanemaaijer R, Sorsa T, Konttinen YT, et al. Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and deoxycycline. J Biol Chem 1997; 272: 31504-31509.
9. Prikk K, Pirilä E, Sepper R, et al. In vivo collagenase-2 expression by human bronchial epithelial cells and monocytes/macrophages in bronchiectasis. J Pathol 2001; 194: 232-238.
10. Wahlgren J, Maisi P, Sorsa T, et al. Expression and induction of collagenases (MMP-8 and -13) in plasma cells associated with bone destructive lesions. J Pathol 2001; 194: 217-224.
11. Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G. Biochemical characterization of human collagenase-3. J Biol Chem 1996; 271: 1544-1550.
12. Sukhova GK, Schonbeck U, Rabkin E, et al. Evidence for increased collagenolysis by interstitial collagenases-1 and -3 in vulnerable human atheromatous plaques. Circulation 1999; 99: 2503-2509.
13. Willmroth F, Peter HH, Conca W. A matrix metalloproteinase gene expressed in human T lymphocytes is identical with collagenase 3 from breast carcinomas. Immunobiology 1998; 198: 375-384.
14. Gadek JE, Kelman JA, Fells G, et al. Collagenase in the lower respiratory tract of patients with idiopathic pulmonary fibrosis. N Engl J Med 1979; 301: 737-742.
15. O'Connor CM, Odlum C, van Breda A, Power C, FitzGerald MX. Collagenase and fibronectin in bronchoalveolar lavage fluid in patients with sarcoidosis. Thorax 1988; 43: 393-400.
16. Fukada Y, Ishizaki M, Kudoh S, Kitaichi M, Yamanaka N. Localization of matrix metalloproteinases-1, -2 and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung disease. Lab Invest 1998; 78: 687-698.
17. Mautino G, Henriquet C, Gougat C, et al. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest 1999; 79: 39-47.
18. Lemjabbar H, Gosset P, Lechapt-Zalcman E, et al. Overexpression of alveolar macrophage gelatinase B (MMP-9) in patients with idiopathic pulmonary fibrosis. Effects of steroid and immunosuppressive treatment. Am J Respir Cell Mol Biol 1999; 20: 903-913.
19. Agostini C, Garbisa S, Trentin L, et al. Pulmonary alveolar macrophages from patients with active sarcoidosis express type IV collagenolytic protenaise. An enzymatic mechanism for influx of mononuclear phagocytes at sites of disease activity. J Clin Invest 1989; 84: 605-612.
20. Johnson IDA, Prescott RJ, Chalmers JC, Rudd RM. 1997. British Thoracic Society study of cryptogenic fibrosing alveolitis: current presentation and initial management. Thorax 52: 38-44.
21. Müller NL, Mawson JB, Mathieson JR, Abboud R, Ostrow DN, Champion P. Sarcoidosis: correlation of extent of disease at CT with clinical, functional, and radiographic findings. Radiology 1989; 171: 613-618.
22. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Resp Crit Care Med 1997; 156: 240-247.
23. Finlay GA, Russell KJ, McMahon KJ, et al. Elevated levels of matrix metalloproteinases in bronchoalveolar lavage fluid of emphysema patients. Thorax 1997; 52: 502-506.
24. Overall CM, Wrana JL, Sodek J. Independent regulation of collagenase, 72 kD progelatinase and metalloproteinase inhibitor expression in human fibroblasts by transforming growth factor-β. J Biol Chem 1989; 264: 1860-1869.
25. Freije JM, Diez-Itza I, Balbin M, et al. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269: 16766-16773.
26. Nwomeh BC, Liang HX, Cohen IK, Yager DR. MMP-8 is the predominant collagenase in healing wounds and non-healing ulcers. J Surg Res 1999; 81: 189-195.
27. Ward K, O'Connor CM, Odlum C, Power C, FitzGerald MX. Pulmonary disease progress in sarcoid patients with and without bronchoalveolar lavage collagenase. Am Rev Respir Dis 1990; 142: 636-641.
28. Pardo A, Barrios RB, Gaxiola M, et al. Increase of lung neutrophils in hypersensitivity pneumonitis is associated with lung fibrosis. Am J Respir Crit Care Med 2000; 161: 1698-1704.
29. Segura-Valdez L, Pardo A, Gaxiola M, Uhal B, Becerril C, Selman M. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest 2000; 117: 684-694.
30. Emonard H, Takiya C, Dreze S, Cordier JF, Grimaud JA. Interstitial collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3) released by human fibroblasts cultured on acellular sarcoid granulomas (sarcoid matrix complex, SMC). Matrix 1989; 9: 382-388.
31. SiltzBach LE. Sarcoiodosis: clinical features and management. Med Clin North Am 1967; 51: 483-502.
32. Choi KH, Lee HB, Jeong MY, et al. The role of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in cryptogenic organising pneumonia. Chest 2002; 121: 1478-1485.